NASDAQ:BTAI

Bioxcel Therapeutics Stock Predictions

etoro logo Buy BTAI
*Your capital is at risk
$1.16
-0.0300 (-2.52%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

BTAI Prediction Chart

BTAI Predictions History

Latest community submissions for BTAI.
Predictor Target Session Target Price Result Direction Accuracy Score
May 14, 2026 $1.21 +1.86% $1.21 V 99.82% 6
May 14, 2026 Bullish $1.21 V 1
Feb 9, 2026 $1.55 +3.38% $1.57 V 98.77% 2
Feb 9, 2026 $1.53 +2.11% $1.57 V 97.56% 1
Feb 9, 2026 Bullish $1.57 V 1
Jan 27, 2026 $1.82 +3.02% $1.77 X 96.98% 0
Jan 27, 2026 $1.80 +1.89% $1.77 X 98.11% 0
Jan 27, 2026 Bullish $1.77 X 0
Jan 21, 2026 $1.95 +3.10% $1.84 X 94.10% 0
Jan 21, 2026 $1.93 +1.94% $1.84 X 95.29% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BTAI with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOXCEL THERAPEUTICS INC.
BioXcel Therapeutics
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE